"Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency." Neurology - Neuroimmunology Neuroinflammation
6.6
(2019):
e628.
Web. 22 Jan. 2022.
Advertisement
A peer-reviewed clinical and translational neurology open access journal
